Skip to content

NELSON LABS

Active Private limited companyfounded 1990active for 35 yearsRomeinse straat 12, 3001 LeuvenKBO/BCE: BE 0442.395.719 subsidiary of STERIGENICS#2 company by total assets in Flemish Brabant, Research and development sector
Part of the group STERIGENICS 3 companies in 2 countries
See the group

Board

3 directors, 1 in day-to-day management, 1 auditor, last change in July 2026
Schrawder Joseph A
Director
since 01-01-2021 term until 03-05-2027
listed in the 2025 annual accounts, filed on 27-07-2026
GARA BV
Director and managing director, permanent representative Kurt Marcel Ursula PEETERS
director since 30-11-2024 managing director appointed by deed of 24-02-2025 term without a fixed end
listed in the 2025 annual accounts, filed on 27-07-2026
Director
appointed by deed of 10-08-2026 term without a fixed end
Statutory auditor, permanent representative HEMSCHOOTE Piet
current term since 15-09-2023 3-year term from 2023
listed in the 2025 annual accounts, filed on 27-07-2026
GARA
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Artikel 12. Externe vertegenwoordiging De vennootschap wordt jegens derden en in rechte als eiser of als verweerder tevens geldig…”
deed of 10-08-2026
Permanent representatives 1
Kurt Marcel Ursula PEETERS
Permanent representative, for GARA
appointed by deed of 10-08-2026

Office holders in the KBO →

Mandates through the years

12 names, the dashed line is today
Schrawder Joseph A
Director
GARA
Director, Managing director
Eric Meyers
Managing director
BOLLEN Jos
Director
Jeff Nelson
Director
LeadershipBoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
  • Schrawder Joseph A
    • Director, from 01-01-2021 to date
  • GARA
    • Director, from 30-11-2024 to date
    • Managing director, appointed by deed of 24-02-2025, still in office
  • Riaz Amirali BANDALI
    • Director, appointed by deed of 04-08-2026, still in office
  • Ernst et Young Reviseurs d'Entreprises
    • Statutory auditor, from 21-04-2021 to date
  • Joseph A. Shrawder
    • Director, appointed by deed of 18-03-2021, until 30-06-2026
  • Eric Meyers
    • Director, appointed by deed of 18-03-2021, until 30-11-2024
    • Managing director, appointed by deed of 26-04-2021, until 30-11-2024
  • Bruce T. Krarup
    • Director, appointed by deed of 18-03-2021, until 03-03-2023
  • BOLLEN Jos
    • Managing director, until 31-12-2020
    • Managing director, until 18-03-2021
    • Director, appointed by deed of 02-09-2021, no longer listed in the 2025 annual accounts
  • Joseph Bollen
    • Director, until 30-06-2021
  • Jeff Nelson
    • Director, until 18-03-2021
  • Petras Michael
    • Director, until 18-03-2021
  • Scott Leffler
    • Director, until 18-03-2021

Control

Parent
Equity €469.5m
Profit €93.9m in 2025 (profit €375.8m in 2024)
Checked score 95
99.58%
This company
NELSON LABS
Equity €595.3m
Profit €38.1m in 2025

Further up the chainSotera Health Holdings LLC US 100%

and 1 other shareholder

Capital

Contribution
€347,500
Shares
278
Contribution per share
€1,250
Equity per share
€2,141,436 in 2025
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
Sotera Health Holdings LLC US
consolidates
GTCR US
consolidates until 2019
Sotera Health LLC US
consolidates until 2018
Toxikon US
consolidates until 2016
Owners as a list

Source: shareholder structure in its own accounts, parent in its own accounts, lists of holdings in the owners' accounts

Articles of association

Name, seat, purpose and duration
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 10-08-2026 (in Dutch)
Board and representation
Daily managementDay-to-day management handles the everyday running of the business without the full board.
The board decides whether the delegates act alone or jointly
deed of 10-08-2026 (in Dutch)
Board ruleThese rules set how the board is made up, meets and takes decisions.
“Alle handelingen die nodig of dienstig zijn tot verwezenlijking van het voorwerp, gewone meerderheid van de stemmen van de aanwezige of…”
deed of 10-08-2026 (in Dutch)
Power of attorneyA power of attorney lets someone perform specific acts on the company's behalf.
“Susana Gonzalez Melon”
“Hannelore De Bie”
“Dries Remeysen”
deed of 04-08-2026 (in Dutch)
General meeting and financial year
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Monday of May at 14:00
deed of 10-08-2026 (in Dutch)
Audit, dissolution and liquidation
Dissolution ruleThe articles set when and by whom the company can be dissolved.
“Bij wet bepaalde gevallen, besluit algemene vergadering beraadslagend op wijze door wet vereist”
deed of 02-09-2021 (in Dutch)
Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
“Alle machten genoemd in artikel 2:87 Wetboek van vennootschappen en verenigingen zonder bijzondere machtiging, algemene vergadering kan ten…”
deed of 02-09-2021 (in Dutch)

Shareholders

2 owners

Owners 2

Capital transactions

Capital over time
  1. 10-08-2026 Converted to available equity
  2. 13-12-2024 Capital increase of €108,911,597.93 · 37 new shares at €2,943,556.70 per share
  3. 13-11-2024 Capital increase of €404,839,944.73 · 141 new shares at €2,870,644.66 per share
  4. 02-09-2021 Capital stated in the deed · €125,000 · 100 shares

Next steps